AGREEMENT Strain Development, Process Development and Manufacturing of Clinical Grade Material of a Fel d1 MAT Fusion Protein between ImVisioN GmbH, Feodor Lynen Strasse 5, Hannover (IVN) and Strathmann Biotec AG, Habichthorst 30, 22459 Hamburg,...Strain Development, Process Development and Manufacturing Agreement • September 1st, 2006 • Imvision Therapeutics Inc.
ImVisioN GmbH is a biotechnology company based in Hannover, Germany, and focused on the development of novel immuntherapies based on its MAT (Modular-Antigen-Transporter) technology platform to treat allergic diseases, (chronic) infectious diseases and possibly cancer.
